R.PR
REGISTERED-PRINCIPAL REGISTER
04/26/2022
Back to search
Official data from USPTO
ALZECURE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
04/26/2022
Classification
Registered
Trademark type
Word
Nice classes
5, 42
Filing date
04/30/2018
Registration date
04/26/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/26/2022
Last transaction
04/26/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
HUDDINGE, SE
Examiner
SABLE, ERIC
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
S. A. (pessoa física)
Representatives
Trevor P. Schmidt Hutchison PLLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalveterinary and medical preparations for treating Alzheimer'scognitive disorderstraumatic brain injurysleep apnea and Parkinson's disease; Pharmaceutical substances for treatment and easement of Alzheimer's diseaseonly for human use
Class 42
Development of pharmaceutical substances for treatment and easement of Alzheimer's diseaseonly for human use; Scientific and technological servicesconducting early evaluations in the field of new pharmaceuticalspharmaceutical drug development servicespharmaceutical product evaluation and pharmaceutical research and development; scientific research and designscientific research in the field of pharmaceuticals; Research in relation to pharmaceuticals; Research and development of vaccines and medicines; Conducting early stage evaluations in the field of new pharmaceuticals; Pharmaceutical drug development services; Drug discovery services; Technical data analysis servicesdata analysis through data mining; Computer-supported technical analysis serviceschemical analysisdata analysis through data mining
Publications
History of USPTO decisions and trademark events.
31 publications found
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
03/23/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/23/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
02/14/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
02/14/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/11/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/16/2021
PUBO
PUBLISHED FOR OPPOSITION
11/16/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/27/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/14/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
08/30/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/11/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/11/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/11/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/15/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
09/02/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
03/02/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
09/02/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/01/2019
GNSL
LETTER OF SUSPENSION E-MAILED
03/01/2019
CNSL
SUSPENSION LETTER WRITTEN
03/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/01/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/01/2019
ALIE
ASSIGNED TO LIE
02/26/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/21/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/21/2018
GNRT
NON-FINAL ACTION E-MAILED
08/21/2018
CNRT
NON-FINAL ACTION WRITTEN
08/21/2018
DOCK
ASSIGNED TO EXAMINER
08/20/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/09/2018
NWAP
NEW APPLICATION ENTERED
05/03/2018
Continuous trademark protection
Get notified about every new filing that threatens ALZECURE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.